The trademark application MART was filed by Affinia Therapeutics Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on March 10, 2022, and it was registered by office on June 17, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Gene therapy products
Biopharmaceutical preparations
Biological preparations
Therapeutic products for medical and clinical gene therapy
All of the above for the treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system.
The mark was filed in class 42 with Scientific and medical research and development services in the field of treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system.